PPARGC1A and Duchenne muscular dystrophy: In a physiological and pathophysiological context, elevation of PGC-1α in muscle promotes a high endurance phenotype and ameliorates various muscle diseases with different etiologies, including Duchenne muscular dystrophy (Handschin et al., 2007c), denervation-induced fiber atrophy (Sandri et al., 2006), or sarcopenia (Wenz et al., 2014), respectively.